Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

32.30SEK
21 Sep 2018
Change (% chg)

-0.35kr (-1.07%)
Prev Close
32.65kr
Open
32.65kr
Day's High
32.65kr
Day's Low
32.15kr
Volume
364,648
Avg. Vol
763,533
52-wk High
38.37kr
52-wk Low
25.25kr

Latest Key Developments (Source: Significant Developments)

Karo Pharma Rights Issue Fully Subscribed
Friday, 1 Jun 2018 02:00am EDT 

June 1 (Reuters) - KARO PHARMA AB ::PRESS RELEASE - KARO PHARMA'S RIGHTS ISSUE FULLY SUBSCRIBED.IN TOTAL, RIGHTS ISSUE HAVE BEEN SUBSCRIBED TO APPROXIMATELY 121.8 PERCENT..WILL THROUGH RIGHTS ISSUE RAISE APPROXIMATELY SEK 1,315M BEFORE DEDUCTION OF ISSUE COSTS..  Full Article

Karo Pharma Intends To Propose Dividend Of SEK 0.30 Per Share
Tuesday, 3 Apr 2018 02:00am EDT 

April 3 (Reuters) - KARO PHARMA AB ::INTENDS TO PROPOSE DIVIDEND OF SEK 0.30 PER SHARE.  Full Article

Karo Pharma Acquires Major Product Portfolio for EUR 260 Mln
Thursday, 1 Mar 2018 02:00am EST 

March 1 (Reuters) - Karo Pharma Ab ::KARO PHARMA ACQUIRES A MAJOR PRODUCT PORTFOLIO.‍ACQUIRES A PRODUCT PORTFOLIO FROM DANISH PHARMACEUTICAL COMPANY LEO PHARMA A/S FOR 260 MEURO​.‍ACQUISITION IS EFFECTIVE FROM 4TH OF APRIL 2018​.SAYS ‍ACQUIRES A PRODUCT PORTFOLIO FROM DANISH PHARMACEUTICAL COMPANY LEO PHARMA A/S FOR 260 MEURO, EFFECTIVE FROM 4TH OF APRIL 2018.​.‍ACQUISITION WILL BE FINANCED BY A COMBINATION OF NEW LOANS AND VIA A RIGHTS ISSUE​.  Full Article

Karo Pharma AB Q4 Adjusted EBITDA Rises To SEK 41.8 Mln
Thursday, 22 Feb 2018 02:00am EST 

Feb 22 (Reuters) - Karo Pharma Ab ::Q4 NET SALES SEK 238.7 MILLION VERSUS SEK 96.5 MILLION YEAR AGO.Q4 ADJUSTED EBITDA SEK 41.8 MILLION VERSUS SEK 28.9 MILLION YEAR AGO.  Full Article

Karo Pharma Rights Issue Subscribed To 170 Percent
Thursday, 4 Jan 2018 02:00am EST 

Jan 4 (Reuters) - KARO PHARMA AB ::RIGHTS ISSUE SUBSCRIBED TO 170 PERCENT WITH PROCEEDS AT ABOUT SEK 794.3 MILLION BEFORE ISSUE COSTS.  Full Article

Karo Pharma: New Issue To Provide Up To SEK 794.3 Ml‍n Before Issue Costs
Friday, 8 Dec 2017 10:30am EST 

Dec 8 (Reuters) - Karo Pharma Ab ::SAYS NEW ISSUE TO PROVIDE UP TO SEK 794.3 ML‍N BEFORE ISSUE COSTS.  Full Article

Karo Pharma Chairman Called For Inquiry For Inside Trading
Thursday, 30 Nov 2017 02:55am EST 

Nov 30 (Reuters) - Karo Pharma Ab ::CHAIRMAN CALLED IN TO INQUIRY FROM POLICE FOR INSIDE TRADING.BOARD CONCLUDES THE THAT CHAIRMAN HAS ACTED CORRECTLY AND DID NOTHING WRONG, AS PER ITS INVESTIGATION.  Full Article

Karo Pharma signs agreement with Marinomed Biotech
Monday, 27 Nov 2017 02:00am EST 

Nov 27 (Reuters) - Karo Pharma Ab ::KARO PHARMA ANNOUNCES AGREEMENT WITH THE AUSTRIAN PHARMACEUTICAL COMPANY MARINOMED BIOTECH AG.‍WILL MARKET A PATENTED PRODUCT FOR COMMON COLD & FLU SYMPTOMS IN SWEDEN, NORWAY AND FINLAND.​.‍AGREEMENT IS LONG TERM (10 YEARS).​.  Full Article

Karo Pharma to carry out new issue
Wednesday, 8 Nov 2017 02:00am EST 

Nov 8 (Reuters) - KARO PHARMA AB ::TO CARRY OUT NEW ISSUE WITH PROCEEDS AT ABOUT SEK 800 MILLION BEFORE ISSUE COSTS IF FULLY SUBSCRIBED.  Full Article

Karo Pharma Q3 EBITDA sharply up yr/yr​
Thursday, 2 Nov 2017 03:00am EDT 

Nov 2 (Reuters) - Karo Pharma Ab :Says ‍net sales amounted to MSEK 418.9 (250.8), whereof Q3 MSEK 137.1 (85.2)​.Says ‍EBITDA amounted to MSEK 127.5 (22.8), whereof Q3 MSEK 34.0 (10.2)​.  Full Article

BRIEF-Karo Pharma Determines Terms For Rights Issue

* THE TERMS FOR KARO PHARMA'S RIGHTS ISSUE HAVE BEEN DETERMINED